SOP Guide for Pharma

Ointments: SOP for Visual Inspection of Ointments – V 2.0

SOP for Visual Inspection of Ointments – V 2.0

Procedure for Visual Inspection of Ointments

Department Quality Control (QC)/Quality Assurance (QA)/Production
SOP No. SOP/Ointment/065
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the method for performing visual inspection of ointments to ensure product quality, uniformity, and compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all personnel in the Quality Control (QC), Quality Assurance (QA), and Production departments responsible for conducting visual inspections of ointments during in-process control, finished product evaluation, and batch release.

3. Responsibilities

  • Quality Control Analyst: Conducts visual inspection and records observations.
  • Quality Assurance Personnel: Verifies and approves inspection results.
  • Production Supervisor: Ensures that ointment batches conform to visual inspection criteria.
  • R&D Team (if applicable): Investigates deviations and suggests corrective actions.

4. Accountability

The QC and QA Managers are accountable for ensuring that visual inspections are conducted accurately and documented as per regulatory and GMP standards.

5. Procedure

5.1 Equipment and Materials

  • Standardized visual inspection area with appropriate lighting
  • White and black background plates
  • Magnifying glass (if required)
  • Clean glass containers for sample observation
  • Sample collection tools
  • Data recording sheets

5.2 Pre-Inspection Preparations

  • Ensure that the inspection area is free from dust and contaminants.
  • Adjust lighting to a minimum of 1000 lux.
  • Inspect
ointment samples at room temperature (25°C ± 2°C).
  • Ensure personnel wear gloves and other protective equipment.
  • 5.3 Visual Inspection Criteria

    • Appearance: The ointment should have a uniform texture and color.
    • Foreign Particles: The sample should be free from visible contamination.
    • Phase Separation: No sign of oil or water phase separation should be observed.
    • Clumping or Grittiness: The formulation should be smooth and free from lumps.
    • Color Consistency: Should match the reference standard for the product.
    • Air Bubbles: The product should be free from excessive trapped air.
    • Odor: The ointment should have the expected scent and no off-odor.

    5.4 Inspection Method

    • Take a representative sample from the batch.
    • Place a small amount on a white background plate and observe under adequate lighting.
    • Check for uniformity, color, and presence of any foreign particles.
    • Perform a secondary check on a black background plate for contrast detection.
    • Use a magnifying glass if necessary to examine smaller particles.
    • Record observations in the Visual Inspection Log.

    5.5 Acceptance Criteria

    • The ointment should be uniform in texture and free from any visual defects.
    • No foreign particles or phase separation should be observed.
    • Any deviations must be investigated and documented.

    5.6 Documentation

    • Record all visual inspection observations in the Visual Inspection Log.
    • Document batch numbers and inspection parameters.
    • QA personnel must review and approve results before batch release.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control

    7. Documents

    • Visual Inspection Log (Annexure-1)
    • Ointment Batch Inspection Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • USP <790> – Visible Particulates in Injections
    • ICH Q6A – Specifications: Test Procedures and Acceptance Criteria

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Visual Inspection Log

    Date Batch Number Sample Description Observations Result Verified By
    01/02/2025 OINT-101 Uniform, white ointment No visible defects Pass QA Officer
    02/02/2025 OINT-102 Off-white, smooth texture No foreign particles Pass QA Officer

    Annexure-2: Ointment Batch Inspection Report

    Date Batch Number Inspection Criteria Acceptance Criteria Result Final Status Approved By
    01/02/2025 OINT-101 Appearance Uniform, smooth Pass Approved QA Head
    02/02/2025 OINT-102 Foreign Particles None visible Pass Approved QA Head

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Exit mobile version